Acute Diabetes Complications After Transition to a Value-Based Medication Benefit

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Preventive Drug Lists Reduce Income-Related Disparities in Medication Adherence Over 2 Years2025
2. 21180-OR: Health Effects of Two Strategies to Enhance Health Care Affordability: Medication-Targeted vs. Broad Out-of-Pocket Cost Reductions2026
3. 3577-P: Employee Diabetes Program Effects on Time to Reach Glycemic Goals and Improved Care in the Ambulatory Care Setting2024
4. 41981-P: Impact of Medicare Part D Cost Sharing on Utilization of Insulin and Novel Diabetes Medications2026
5. 51354-P: Diabetes-Related Acute Complications during the COVID-19 Pandemic among Medicare Fee-for-Service Beneficiaries2024